Coronavirus Vaccine

On Wednesday, a U.S. District Judge denied a request by Democratic presidential candidate Robert F. Kennedy Jr. for a temporary restraining order to prevent Google, owned by  Alphabet Inc (NASDAQ:GOOGL) (NASDAQ:GOOG), from removing his videos from YouTube, citing the platform...

Biotech stocks continued to remain under pressure in the week ended Sept. 11, swayed by the volatility that was evident in the broader market. The week also witnessed a flurry of news flow on the coronavirus vaccine front. Even as nine vaccine makers released a pledge to put safety first,...

AstraZeneca plc (NYSE: AZN) can heave a sigh of relief following resumption of its coronavirus vaccine study that was voluntarily paused by the company. What Happened: The U.K. pharma giant said U.K. regulatory agency, the Medicines Health Regulatory Authority (MHRA) has given its...

AstraZeneca Plc (NYSE: AZN) announced Monday that its COVID-19 vaccine candidate is moving into phase three clinical trials for all adult age groups in the United States. What Happened:  The development of AZD1222 is already in the late stages of testing in the United...

Tesla Inc. (NASDAQ: TSLA) Chief Executive Officer Elon Musk on Sunday said he would be visiting Germany later in the week to assess the progress on some of the automaker's projects in the country. What Happened: In response to a Twitter user asking him about progress on the company's plans...

The United States Food and Drug Administration is willing to expedite the COVID-19 vaccine authorization process, including granting emergency use authorization to a candidate before it completes late-stage clinical trials, according to Chairman Stephen Hahn. What Happened: Hanh told the...

CanSino Biologics Inc (OTC: CASBF) partnership with Canada’s National Research Council on a COVID-19 vaccine came to an end Wednesday, Reuters reported. What Happened: The NRC cited CanSino’s lack of authority to ship the vaccine to Canada as the reason for the falling through of the...

COVID-19 vaccine makers are lobbying the European Union for protection against lawsuits, should problems arise with new therapies, the Financial Times reported Tuesday. What Happened: Vaccines Europe, a division of the European Federation of Pharmaceutical Industries and Associations, which...

Johnson & Johnson (NYSE: JNJ) plans on enrolling up to 60,000 people in a coronavirus vaccine trial, likely as part of a global development and regulatory approval strategy, ex-FDA Commissioner Scott Gottlieb said Friday on CNBC's "Squawk Box." J&J's Global Approval...

Pfizer Inc (NYSE: PFE), and its partner BioNTech SE (NASDAQ: BNTX), announced positive results for the Phase 1 trial of their second COVID-19 vaccine candidate, stating that the latest vaccine candidate had fewer side effects than their first. What Happened The second vaccine candidate called...

CanSino Biologics Inc (OTC: CASBF) has become the first company to secure a patent for its COVID-19 vaccine in China, Reuters reported Sunday. What Happened The Tianjin, China-based company's patent for its Ad5-nCOV vaccine against COVID-19 stands approved by China’s National...

Novavax, Inc (NASDAQ: NVAX) announced Friday it has reached terms with the government of the United Kingdom to supply 60 million doses of its COVID-19 vaccine, subject to success of pending clinical trials. What Happened The Maryland-based company will supply the U.K. with its NVX-CoV2373...

AstraZeneca plc’s (NYSE: AZN) COVID-19 vaccine will be produced by Mexico and Argentina for Latin American countries except for Brazil, according to government officials of the two countries, AlJazeera reported Wednesday. What Happened The countries will produce 150 million to 250 million...

Activist investor and Trian Partners CEO Nelson Peltz told CNBC on Thursday's "Halftime Report" he bought shares of unnamed companies that were "beaten down too much." Peltz's Buying Strategy The activist investor isn't disclosing what specific stocks he has been...

Shares of Novavax, Inc. (NASDAQ: NVAX) gained more than 25% by Monday, leading a notable short seller to tweet his thoughts on the stock. What Happened Novavax announced on April 16 it will start a COVID-19 vaccine called SARS-CoV-2 Recombinant Spike Protein Nanoparticle, NVX-CoV2373 within the...